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The pentose phosphate pathway operates at an elevated level in rat kidney following induction of diabetes 
and in the compensatory hypertrophy following unilateral nephrectomy in control and alloxan-diabetic 
rats, as shown by the yields of 14Coz from [l-‘4C]glucose, [6-i4C]glucose and 3Hz0 yields from 
[2-3H]glucose. The elevated flux through the pentose phosphate pathway is correlated with the increased 
RNA content and weight of the kidney. The direct utilization of NADPH for reductive synthetic reactions 
and the potential for indirect utilization via the sorbitol route and the linked transhydrogenase r actions 
of the glucuronate-xylulose pathway, for NADH and ATP generation, are also discussed. 
[‘4C]Glucose utilization Pentose phosphate pathway Unilateral nephrectomy 
Correlation with growth Rat kidney Experimental diabetes 
1. INTRODUCTION or whether any single pathway is 
involved. 
There is an apparent anomaly in experimental 
diabetes in that there is a loss of body and liver 
weight concomitant with an accelerated rate of 
renal growth, this latter occurring shortly after the 
induction of diabetes [l-4] and it has been shown 
that treatment of diabetic rats with insulin will pre- 
vent this kidney growth [4]. There is evidence for 
a decrease in nucleic acid and protein synthesis in 
liver and muscle in diabetes but an increase in these 
biosynthetic routes in the kidney under similar con- 
ditions [5-91. Even more striking, perhaps, is the 
observation [4] that the already-considerable 
kidney growth that follows unilateral nephrectomy 
(UN) is enhanced even further when the operation 
is performed on diabetic animals. 
A relationship exists between the blood glucose 
level and the rate of kidney growth [lo]; this study 
attempts to establish whether the increased kidney 
growth in diabetic animals is related to multiple 
changes in the pattern of carbohydrate metabolism 
particularly 
An increase in the flux of glucose through the 
pentose phosphate pathway (PPP) in the kidney 
has been reported to occur following the induction 
of diabetes [11,121 and in the compensatory hyper- 
trophy following UN [ 131 possibly related to the in- 
creased requirement for ribose 5-phosphate and 
NADPH in biosynthetic reactions and, in the case 
of diabetes, to the changes in acid-base and elec- 
trolyte balance [lo- 161. 
There is a direct correlation between the activity 
of the PPP and the rate of kidney growth while no 
such correlation was observed between kidney 
growth and the flux of glucose through the 
glycolytic-tricarboxylic acid cycle route. 
2. MATERIALS AND METHODS 
2.1. Animals 
Diabetes was induced in adult male Wistar rats 
by intravenous injection of alloxan (50 mg/kg 
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Table 1 
Activity of enzymes of the pentose phosphate pathway and key enzymes of the glycolytic route in kidney from 
control and alloxan-diabetic rats with and without unilateral nephrectomy 
Enzyme Control UN-Control UN-C Diabetic D/C UN-Diabetic UN-D UN-D 
(Q) 
Units. g kidney-’ 
Glucose phosphorylation 
Hexokinase 
Soluble 0.720 ? 0.051 0.685 ? 0.029 95 0.807 -t 0.059 112 0.615 k 0.031 85 76a 
Particulate 0.754 f 0.060 0.753 % 0.081 99 0.730 k 0.080 96 0.717 5 0.112 95 98 
Pentose phosphate 
pathway 
G6P dehydrogenase 1.34 I!I 0.13 1.30 t 0.10 97 1.32 f 0.12 98 1.31 * 0.09 97 100 
6GP dehydrogenase 0.880 + 0.03 0.96 k 0.08 109 0.99 f 0.04 112 1.15 k 0.09 130” 116 
Transketolase 0.990 f 0.10 1.06 + 0.17 107 1.09 & 0.15 110 1.01 + 0.12 102 92 
Transaldolase 1.45 f 0.15 1.30 + 0.12 89 1.42 f 0.11 97 1.32 + 0.09 91 93 
Glycolytic route 
Phosphofructokinase 
Pyruvate kinase 
0.838 + 0.111 0.996 ? 0.095 119 1.39 + 0.23 165” 1.39 +- 0.22 165” 100 
19.3 -t 1.70 17.5 * 1.94 91 21.6 * 1.94 111 17.6 k 1.90 91 81 
Units. kidney-‘. 100 g body wt-’ 
Glucose phosphorylation 
Hexokinase 
Soluble 0.229 + 0.016 0.327 + 0.014 143b 0.646 + 0.047 282’ 0.579 + Ct.029 252’ 89 
Particulate 0.240 + 0.019 0.360 ?I 0.039 150a 0.584 + 0.064 243’ 0.675 + 0.105 281b 115 
Pentose phosphate 
pathway 
G6P dehydrogenase 0.426 rt 0.041 0.621 ? 0.046 146b 1.05 + 0.10 246’ 1.23 rt 0.08 288b 117 
6GP dehydrogenase 0.280 * 0.009 0.459 + 0.038 164b 0.79 ?Z 0.03 282’ 1.08 _t 0.08 385’ 137” 
Transketolase 0.315 + 0.032 0.507 + 0.081 161” 0.87 * 0.12 276’ 0.95 + 0.11 301’ 109 
Transaldolase 0.461 * 0.048 0.621 + 0.050 135” 1.14 !I 0.08 247’ 1.24 k 0.08 268’ 109 
Glycolytic route 
Phosphofructokinase 
Pyruvate kinase 
0.266 + 0.035 0.476 k 0.045 17gb 1.11 + 0.19 417b 1.31 + 0.22 492b 118 
6.14 + 0.53 8.36 + 0.93 136 17.2 + 1.5 280’ 16.6 + 1.79 270’ 96 
(6) (6) (6) 
Fisher’s p-values: a p < 0.05; b p < 0.01; ‘p < 0.001 
The values are given as means + SEM; (no. obs.); a unit of enzyme activity is defined as pmol substrate converted/min 
at 25°C. AI1 enzyme activities are for the dialysed high speed supernatant fraction with the exception of hexokinase for 
which activities of soluble and particulate (mitochondrial + microsomal) fractions are given. Kidney weight and enzyme 
activity. kidney-‘. 100 g body wt-’ refer to a single kidney. The initial body weight was 302 & 14 g and kidney weight 
was 1.26 * 0.08 g (17 values). Rats were unilaterally nephrectomized (UN) 5 days after administration of alloxan and 
used 6-7 weeks later (see section 2) 
Abbreviations: C, control; UN-C, UN-control; D, diabetic; UN-D, UN-diabetic 
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body wt). Two units of insulin (Monotard MC, 
Novo) were injected daily for the following 5 days 
at which time half the control and diabetic animals 
underwent unilateral nephrectomy, the diabetic 
groups continuing the insulin treatment for 
another 5 days. The animals were killed 6-7 weeks 
after alloxan treatment. The HbAi was determined 
as in [17]. 
2.2. Flux of glucose through alternative pathways 
The conversion of specifically labeled glucose to 
14C02 and 3Hz0 y b kidney cortex slices incubated 
for 1 h in Krebs-Ringer bicarbonate medium con- 
taining 5 mM glucose (control and UN-control 
groups) and 20 mM glucose (diabetic and UN- 
diabetic groups) and 0.5 &i [‘4C]glucose or 1 &i 
[2-3H]glucose was measured as in [ll]. The ar- 
tificial electron acceptor phenazine methosulphate 
(PMS) was present at 0.1 mM final cont. 
3. RESULTS AND DISCUSSION 
Table 1 shows the yield of i4C02 from specifi- 
cally labelled glucose. The following pattern of 
change is apparent: 
(9 
(ii) 
(iii) 
(iv) 
The rate of glucose phosphorylation 
([2-3H]glucose --* ‘HzO) is decreased relative 
to the control group in UN-control, diabetic 
and UN-diabetic groups; 
The glycolytic pathway and pyruvate 
dehydrogenase ([3,4-14C]glucose -+ 14C02) is 
also significantly lower in these groups; 
The flux of glucose through the tricarboxylic 
acid cycle ([6-14C]glucose + 14C02) is 
unchanged; 
In sharp contrast to the other metabolic 
routes, the activity of the PPP (Cl-C6) in- 
creases dramatically in UN-controls, diabetic 
and UN-diabetic kidney. 
Examination of the ‘proportionate yields’ of 14C02 
from labelled glucose, which indicates the amount 
of glucose utilized via an oxidative pathway 
relative to the rate of glucose phosphorylation, 
again reveals the highly significant increase of the 
PPP in the kidney in diabetes and following 
unilateral nephrectomy. In the double-lesioned 
animal there is a 12-fold increase in the proportion 
of glucose oxidized via the PPP. 
The close correlation between the extent of PPP 
activity and kidney hypertrophy is further il- 
lustrated in fig. 1 which draws on these data and 
[ 111. The specific relationship is emphasized by the 
fact that no correlation exists between kidney 
hypertrophy and the flux of glucose through the 
tricarboxylic acid cycle, despite the expected in- 
creased demand of ATP. This finding raises the 
question of the significance of the PPP in kidney 
hypertrophy and of the mechanism by which this 
pathway is stimulated. 
The significance of the increase in the PPP centres 
upon the supply of two important intermediates, 
ribose-5-phosphate, used for nucleotide and nucleic 
acid synthesis, and NADPH which is used for reduc- 
tive biosynthetic reactions including lipogenesis, 
conversion of GSSG -+ GSH, deoxyribonucleotide 
synthesis and in transhydrogenase reactions via 
linked NADPH : NADP+ and NAD+ : NADH steps 
in the sorbitol route and glucuronate xylulose path- 
way. The function of the supply of ribose 
5-phosphate may be of major quantitative impor- 
tance, particularly in view of the rapid rise in the 
RNA content of kidney in uncontrolled diabetes 
and in UN-diabetic rats [15,18]. 
The mechanism of the increased flux of glucose 
through the PPP may rest, in part, on the increas- 
ed blood glucose in the diabetic state and the free 
permeability of the kidney to glucose in the 
absence of insulin. Thus, with normal rat kidney 
cortex slices there is a 5-fold increase in the flow of 
glucose through the PPP when medium [glucose] is 
raised from 5-20 mM [ 111, the higher concentra- 
tion paralleling the glycaemic condition of the 
diabetic state; in [19] sorbitol and fructose ac- 
cumulated in kidney in experimental diabetes. It is 
proposed that in kidney, as in lens, an increased 
flux of glucose through the sorbitol route could act 
as a ‘drive’ to the PPP by reoxidation of NADPH, 
the latter being a powerful inhibitor of the ox- 
idative reactions of this route [20-221. The inter- 
relationship between the oxidative reactions of the 
PPP and the glycolytic route via the activation of 
phosphofructokinase by 6-phosphogluconate [23] 
may also lead to a coordinated increase in in- 
termediates of the glycolytic route, in particular of 
fructose bisphosphate. 
There is increasing interest in the role of sugar 
phosphates and NADPH as regulatory factors in 
protein synthesis, in particular that of glucose 
6-phosphate and fructose bisphosphate play such a 
role [24,25]. The increased availability of glucose 
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Fig. 1. The relationship between flux of glucose through the PPP, pyruvate dehydrogenase and tricarboxylic acid cycle 
and the growth of the kidney in experimental diabetes and unilateral nephrectomy. The pathways and correlation coeffi- 
cients with kidney weights are: (0) PPP, 14C02 yield Cl-C6, r = 0.95, P < 0.001; (0) glycolysis and pyruvate 
dehydrogenase, 14C02 yield [3,4-‘4C]glucose, r = 0.74, P = 0.06; (A) tricarboxylic acid cycle, 14C02 yield 
[6-14C]glucose, r = 0.39, NS; the number of observations are as in table 1, the streptozotocin diabetic group (SD) and 
controls (C-S) each contain 6 values and are from [ 111. The horizontal and vertical lines represent he SEM of the kidney 
weights and 14C02 yields, respectively. Abbreviations: AD, alloxan-diabetic; UN-D and UN-C, unilaterally nephrec- 
tomized diabetic and control groups; C-A, control group for alloxan-diabetic rats 
in the diabetic state and the consequent increase in 
kidney content of glucose and glucose 6-phosphate 
[26] might therefore be key factors influencing pro- 
tein synthesis, as well as RNA synthesis, UDP 
glucose and glycogen synthesis, the stimulation of 
these pathways providing a biochemical network 
linking hyperglycaemia to kidney hypertrophy. 
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